Drug
Incb177054
Incb177054: highest development phase Phase 1/2, developed by Incyte. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Incyte
Trials
| Drug | Phase | Indication |
|---|---|---|
| INCB177054 NCT06873789 | Phase 1/2 | Solid Tumors |
Latest
No recent events.
Follow Incb177054 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.